If pharmaceutical giants Pfizer and Wyeth are allowed to merge, the result will be higher drugs prices, lower quality, and the loss of thousands of jobs, according to a lawsuit seeking to halt the $68 billion merger. The challenge has been filed by pharmacies that do business with the two drug makers which, if combined, would control 40% of the market. Pfizer and Wyeth are currently the first and fourth biggest drug makers in the United States. Plaintiffs argue that the new corporation would have the leverage to sell low-quality drugs at increased prices, and that at least 22,000 jobs would be lost from the joining of Pfizer and Wyeth.